PMID: 8763344DOI: 10.1016/0959-8049(96)00045-7Jun 1, 1996Paper

How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Henk J BroxtermanH M Pinedo

Abstract

No abstract listed.

References

Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin

Apr 1, 1992·International Journal of Cancer. Journal International Du Cancer·C H VersantvoortJ Lankelma

Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines

May 6, 1992·Journal of the National Cancer Institute·C E HerzogA T Fojo

Application of cladistics to the analysis of genotype-phenotype relationships

May 1, 1992·European Journal of Epidemiology·C F SingA R Templeton

Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas

Oct 7, 1992·Journal of the National Cancer Institute·T A HolzmayerI B Roninson

P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport.

Feb 1, 1991·Biochemical Pharmacology·E C SpoelstraJ Lankelma

Flow cytometric analysis of cell cycle-dependent changes in cell thiol level by combining a new laser dye with Hoechst 33342

Jan 1, 1991·Cytometry·M PootP S Rabinovitch

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

Jul 12, 1991·Cell·P M Chaudhary, I B Roninson

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.

Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K E NoonanI B Roninson

Expression of a multidrug-resistance gene in human tumors and tissues

Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A T FojoI Pastan

Quantitative determination of factors contributing to doxorubicin resistance in multidrug-resistant cells

Dec 20, 1989·Journal of the National Cancer Institute·G J SchuurhuisJ Lankelma

Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein

Jun 15, 1988·Biochemical Pharmacology·H J BroxtermanJ Lankelma

Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein binding

Apr 1, 1987·Cancer Letters·H J BroxtermanJ Lankelma

Identification of two distinct regulatory regions adjacent to the human beta-interferon gene

Oct 1, 1983·Cell·K ZinnT Maniatis

P-glycoprotein--a marker of cancer-cell behavior

Nov 23, 1995·The New England Journal of Medicine·H M Pinedo, G Giaccone

Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123

Sep 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S KoizumiS Mizutani

High-affinity monoclonal antibodies against P-glycoprotein

Jul 1, 1995·Clinical Immunology and Immunopathology·T ShiD B Ring

Chemosensitizers to overcome and prevent multidrug resistance?

Nov 1, 1995·Journal of the National Cancer Institute·U A Germann, M W Harding

The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity

Sep 28, 1995·Biochemical Pharmacology·H S MülderJ Lankelma

Evaluation of red blood cell lysing solutions for the detection of intracellular antigens by flow cytometry

Aug 1, 1995·Cytometry·M I Tiirikainen

ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion

Jul 17, 1995·FEBS Letters·N FellerH M Pinedo

Multidrug resistance in lung cancer

Jan 1, 1995·Cancer Treatment and Research·H J BroxtermanS C Linn

Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance

May 4, 1995·International Journal of Cancer. Journal International Du Cancer·C H VersantvoortE G de Vries

Correlation of p-glycoprotein detection by immunohistochemistry with mdr-1 mRNA levels in osteosarcomas. Pilot study

Mar 1, 1995·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·R A KandelI L Andrulis

Kinetic analysis of glutathione in anchored cells with monochlorobimane

Mar 1, 1995·Cytometry·R BarhoumiR C Burghardt

Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line

Apr 1, 1995·Leukemia Research·R A DaveyH Wheeler

Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts

Jun 9, 1995·International Journal of Cancer. Journal International Du Cancer·H J BroxtermanJ Lankelma

Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation

Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G A ThomasP R Twentyman

The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump

Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·G J ZamanH J Broxterman

Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators

Oct 19, 1994·Journal of the National Cancer Institute·C CharpinL Piana

Evaluation of methods for measuring cellular glutathione content using flow cytometry

Apr 1, 1994·Cytometry·D W Hedley, S Chow

Flow cytometric assays of anticancer drug resistance

Mar 20, 1993·Annals of the New York Academy of Sciences·D W Hedley

Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines

Apr 15, 1993·Cancer Research·G J ZamanF Baas

Flow cytometric determination of glutathione in clinical samples

Sep 1, 1995·Cytometry·S Chow, D Hedley

Multidrug resistance proteins and other drug transport-related resistance to natural product agents

Nov 1, 1995·Current Opinion in Oncology·H J BroxtermanJ Lankelma

Instrument-dependent fluorochrome sensitivity in flow cytometric analyses

Sep 15, 1995·Cytometry·J T ChanceD L Cox

Biology of the multidrug resistance-associated protein, MRP

Jun 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D W LoeS P Cole

On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP)

Dec 11, 1995·International Journal of Cancer. Journal International Du Cancer·C H VersantvoortP R Twentyman

Prognostic Relevance of Tn Expression in Breast Cancer

Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·A TsuchiyaI Kimijima

Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia

Oct 6, 2001·Leukemia·M A van der PolG J Schuurhuis

❮ Previous
Next ❯

Citations

Diagnostics of multidrug resistance in cancer

Jan 15, 1999·Pathology Oncology Research : POR·G SzakácsB Sarkadi

Classical multidrug resistance in acute myeloid leukaemia

Mar 1, 1997·Medical Oncology·E Paietta

Clinical efficacy of chemotherapy combined with verapamil in metastatic colorectal patients

May 13, 2011·Cell Biochemistry and Biophysics·Y LiuJ Zhuang

Radiation therapy depletes extrachromosomally amplified drug resistance genes and oncogenes from tumor cells via micronuclear capture of episomes and double minute chromosomes

Feb 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Patricia V SchoenleinJ McCoy

Interspecies differences in P-glycoprotein mediated activity of multixenobiotic resistance mechanism in several marine and freshwater invertebrates

Oct 29, 2000·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·T SmitalB Kurelec

Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs

Jul 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·S SongJ L Au

Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance

Jul 2, 1997·Journal of the National Cancer Institute·B J TrockR Clarke

Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies

Oct 1, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Francesco CreaEnrico Mini

The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms

May 24, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Methvin IsaacJan Jongstra

Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib

Aug 4, 2009·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Henk J BroxtermanHenk M W Verheul

Multidrug resistance-associated protein (MRP1) gene is strongly expressed in gastric carcinomas. Analysis by immunohistochemistry and real-time quantitative RT-PCR

Apr 7, 2005·Histopathology·J LacuevaR Calpena

Quantification of MDR-1 gene expression in canine tissues by real-time reverse transcription quantitative polymerase chain reaction

Jul 28, 2004·Research in Veterinary Science·K CulmseeI Nolte

New cancer therapeutics: target-specific in, cytotoxics out?

May 26, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Henk J Broxterman, Nafsika H Georgopapadakou

A diagnostic tool for monitoring multidrug resistance expression in human tumor tissues

Sep 18, 2002·Analytical Biochemistry·Heidi Schwarzenbach

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

Aug 10, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Zhiwei WangFazlul H Sarkar

In vivo model systems in P-glycoprotein-mediated multidrug resistance

Apr 9, 1998·Critical Reviews in Clinical Laboratory Sciences·W van de VrieA M Eggermont

Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice

Sep 19, 2006·Leukemia Research·Flavia C VasconcelosRaquel C Maia

Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells

Dec 7, 2018·Cellular & Molecular Biology Letters·Huaping HuangXi Li

Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors

Sep 16, 1999·Cytometry·B De MoerlooseJ Philippé

Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells

May 14, 2016·International Journal of Oncology·Lu ZhaoChristiane Josephine Bruns

P7 peptides targeting bFGF sensitize colorectal cancer cells to CPT-11

Nov 6, 2013·International Journal of Molecular Medicine·Wu LuoXiaoping Wu

Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer

Mar 13, 1999·International Journal of Cancer. Journal International Du Cancer·A GiatromanolakiG Fountzilas

Expression of multidrug resistance (MDR)-associated proteins in solid tumors

Jun 7, 2006·Cirugía española·Alfredo ParedesMiguel Echenique-Elizondo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Clinical therapy and HER-2 oncogene amplification in breast cancer: chemo- vs radiotherapy

(opens in new tab)
The Journal of Steroid Biochemistry and Molecular Biology
M StühlingerJ Spona
ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved